Contemporary clinical characteristics, treatment, and outcomes of angiographically confirmed coronary stent thrombosis: Results from a multicenter California registry

Catheterization and Cardiovascular Interventions

Volumn 79, Issue 4, 2012, Pages 550-556

  Yeo, Khung Keong ^a   Mahmud, Ehtisham ^b   Armstrong, Ehrin J ^c   Bennett, William E ^b   Shunk, Kendrick A ^c,d   MacGregor, John S ^e   Li, Zhongmin ^a   Low, Reginald I ^a   Rogers, Jason H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCSD MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

coronary intervention; stent; thrombosis

Indexed keywords

CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RECURRENT DISEASE; REOPERATION; SEX DIFFERENCE; STENT THROMBOSIS; STROKE; SURVIVAL TIME; THROMBUS ASPIRATION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CALIFORNIA; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; DRUG-ELUTING STENTS; FEMALE; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS; STROKE; SURVIVAL ANALYSIS; THROMBECTOMY; THROMBOLYTIC THERAPY; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84857445958     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23011     Document Type: Article

References (18)

1. Ong AT, Hoye A, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Sonnenschein K, Regar E, McFadden EP, Sianos G, van der Giessen WJ, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005; 45: 947-953. (Pubitemid 40342824)
2. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130. (Pubitemid 40617065)
3. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E,. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 354: 1879-1888. (Pubitemid 43872689)
4. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007; 356: 998-1008. (Pubitemid 46376800)
5. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE,. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 356: 1020-1029. (Pubitemid 46376802)
6. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351. (Pubitemid 46685903)
7. Hanna DB, Pfeiffer MR, Sackoff JE, Selik RM, Begier EM, Torian LV,. Comparing the National Death Index and the Social Security Administration's Death Master File to ascertain death in HIV surveillance. Public Health Rep 2009; 124: 850-860.
8. Hill ME, Rosenwaike I,. The Social Security Administration's Death Master File: The completeness of death reporting at older ages. Soc Secur Bull 2001; 64: 45-51.
9. van Werkum JW, Heestermans AA, de Korte FI, Kelder JC, Suttorp MJ, Rensing BJ, Zwart B, Brueren BR, Koolen JJ, Dambrink JH, et al. Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: An analysis of 431 cases. Circulation 2009; 119: 828-834.
10. Kimura T, Morimoto T, Kozuma K, Honda Y, Kume T, Aizawa T, Mitsudo K, Miyazaki S, Yamaguchi T, Hiyoshi E, et al. Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART). Circulation 2010; 122: 52-61.
11. King SB, 3rd, Smith SC, Jr., Hirshfeld JW, Jr., Jacobs AK, Morrison DA, Williams DO, Feldman TE, Kern MJ, O'Neill WW, Schaff HV, et al. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Catheter Cardiovasc Interv 2008; 71: E1-E40.
12. Uren NG, Schwarzacher SP, Metz JA, Lee DP, Honda Y, Yeung AC, Fitzgerald PJ, Yock PG,. Predictors and outcomes of stent thrombosis: An intravascular ultrasound registry. Eur Heart J 2002; 23: 124-132. (Pubitemid 35204230)
13. Keong Yeo K, Daemen J, Rogers JH, Serruys PW,. The use of drug-eluting stents in ST-elevation myocardial infarction. EuroIntervention 2009; 5: 494-500.
14. Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, et al. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med 2009; 360: 1946-1959.
15. Alfonso F, Suarez A, Angiolillo DJ, Sabate M, Escaned J, Moreno R, Hernandez R, Banuelos C, Macaya C,. Findings of intravascular ultrasound during acute stent thrombosis. Heart 2004; 90: 1455-1459. (Pubitemid 39626325)
16. Kedia G, Lee MS,. Stent thrombosis with drug-eluting stents: A re-examination of the evidence. Catheter Cardiovasc Interv 2007; 69: 782-789. (Pubitemid 46867477)
17. Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM,. Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003; 107: 2908-2913. (Pubitemid 36736631)
18. Gurbel PA, DiChiara J, Tantry US,. Antiplatelet therapy after implantation of drug-eluting stents: Duration, resistance, alternatives, and management of surgical patients. Am J Cardiol 2007; 100: 18M-25M.